These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 33961168)

  • 1. Current management of melanoma patients with nodal metastases.
    Han D; van Akkooi ACJ; Straker RJ; Shannon AB; Karakousis GC; Wang L; Kim KB; Reintgen D
    Clin Exp Metastasis; 2022 Feb; 39(1):181-199. PubMed ID: 33961168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy Trial II (MSLT-2).
    Broman KK; Hughes T; Dossett L; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; Frank J; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Farma JM; Deneve JL; Fleming MD; Perez MC; Lowe MC; Olofsson Bagge R; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley G; Hui JYC; Been L; Kruijff S; Kim Y; Naqvi SMH; Sarnaik AA; Sondak VK; Zager JS
    Cancer; 2021 Jul; 127(13):2251-2261. PubMed ID: 33826754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
    Eroglu Z; Broman KK; Thompson JF; Nijhuis A; Hieken TJ; Kottschade L; Farma JM; Hotz M; Deneve J; Fleming M; Bartlett EK; Sharma A; Dossett L; Hughes T; Gyorki DE; Downs J; Karakousis G; Song Y; Lee A; Berman RS; van Akkooi A; Stahlie E; Han D; Vetto J; Beasley G; Farrow NE; Hui JYC; Moncrieff M; Nobes J; Baecher K; Perez M; Lowe M; Ollila DW; Collichio FA; Bagge RO; Mattsson J; Kroon HM; Chai H; Teras J; Sun J; Carr MJ; Tandon A; Babacan NA; Kim Y; Naqvi M; Zager J; Khushalani NI
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
    Broman KK; Hughes TM; Bredbeck BC; Sun J; Kirichenko D; Carr MJ; Sharma A; Bartlett EK; Nijhuis AAG; Thompson JF; Hieken TJ; Kottschade L; Downs J; Gyorki DE; Stahlie E; van Akkooi A; Ollila DW; O'shea K; Song Y; Karakousis G; Moncrieff M; Nobes J; Vetto J; Han D; Hotz M; Farma JM; Deneve JL; Fleming MD; Perez M; Baecher K; Lowe M; Bagge RO; Mattsson J; Lee AY; Berman RS; Chai H; Kroon HM; Teras J; Teras RM; Farrow NE; Beasley GM; Hui JYC; Been L; Kruijff S; Sinco B; Sarnaik AA; Sondak VK; Zager JS; Dossett LA;
    Ann Surg; 2023 May; 277(5):e1106-e1115. PubMed ID: 35129464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease.
    Uppal A; Stern S; Thompson JF; Foshag L; Mizzollo N; Nieweg OE; Hoekstra HJ; Roses DF; Sondak VK; Kashani-Sabet M; Coventry BJ; Cochran AJ; Fujita M; Sim-Shin M; Elashoff D; Elashoff RM; Faries MB
    Ann Surg Oncol; 2020 Jun; 27(6):1970-1977. PubMed ID: 31863416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a scoring system to predict non-sentinel lymph node metastasis in melanoma.
    Cadili A; McKinnon G; Wright F; Hanna W; Macintosh E; Abhari Z; Dabbs K
    J Surg Oncol; 2010 Mar; 101(3):191-4. PubMed ID: 20039281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation after a positive sentinel lymph node biopsy in patients with melanoma.
    Bamboat ZM; Konstantinidis IT; Kuk D; Ariyan CE; Brady MS; Coit DG
    Ann Surg Oncol; 2014 Sep; 21(9):3117-23. PubMed ID: 24833100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era.
    Mitra D; Ologun G; Keung EZ; Goepfert RP; Amaria RN; Ross MI; Gershenwald JE; Lucci A; Fisher SB; Davies MA; Lee JE; Bishop AJ; Farooqi AS; Wargo J; Guadagnolo BA
    Ann Surg Oncol; 2021 Jul; 28(7):3480-3489. PubMed ID: 33856603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of Residual Nodal Disease at Completion Dissection Following Positive Sentinel Lymph Node Biopsy for Melanoma.
    Sinnamon AJ; Song Y; Sharon CE; Yang YX; Elder DE; Zhang PJ; Xu X; Roses RE; Kelz RR; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2018 Nov; 25(12):3469-3475. PubMed ID: 30043316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with sentinel lymph node status and prognostic role of completion lymph node dissection for thick melanoma.
    Boada A; Tejera-Vaquerizo A; Ribero S; Puig S; Moreno-Ramírez D; Quaglino P; Osella-Abate S; Cassoni P; Malvehy J; Carrera C; Pigem R; Barreiro-Capurro A; Requena C; Traves V; Manrique-Silva E; Fernández-Orland A; Ferrandiz L; García-Senosiain O; Fernández-Figueras MT; Ferrándiz C; Nagore E;
    Eur J Surg Oncol; 2020 Feb; 46(2):263-271. PubMed ID: 31594672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma sentinel lymph node biopsy and completion lymph node dissection: A regional hospital experience.
    Williams TS; Tallon B; Adams BM
    J Plast Reconstr Aesthet Surg; 2022 Feb; 75(2):730-736. PubMed ID: 34789434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International multi-institutional management and outcome of melanoma patients with positive sentinel lymph nodes in more than one nodal basin.
    Melstrom LG; Taylor E; Kuk D; Frankel TL; Panageas K; Haydu L; Sabel MS; Thompson JF; Ariyan C; Coit DG; Brady MS
    Ann Surg Oncol; 2014 Dec; 21(13):4324-9. PubMed ID: 24962937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion lymph node dissection in patients with sentinel lymph node positive cutaneous head and neck melanoma.
    Huang K; Misra S; Lemini R; Chen Y; Speicher LL; Dawson NL; Tolaymat LM; Bagaria SP; Gabriel EM
    J Surg Oncol; 2020 Nov; 122(6):1057-1065. PubMed ID: 32654173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Completion Lymph Node Dissection for Sentinel Lymph Node-Positive Melanoma.
    Hieken TJ; Kane JM; Wong SL
    Ann Surg Oncol; 2019 Apr; 26(4):1028-1034. PubMed ID: 30284132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Completion lymphadenectomy for a positive sentinel node biopsy in melanoma patients is not associated with a survival benefit.
    Klemen ND; Han G; Leong SP; Kashani-Sabet M; Vetto J; White R; Schneebaum S; Pockaj B; Mozzillo N; Charney K; Hoekstra H; Sondak VK; Messina JL; Zager JS; Han D
    J Surg Oncol; 2019 Jun; 119(8):1053-1059. PubMed ID: 30883771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
    Eggermont AM
    Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node Biopsy.
    McMasters KM; Egger ME; Edwards MJ; Ross MI; Reintgen DS; Noyes RD; Martin RC; Goydos JS; Beitsch PD; Urist MM; Ariyan S; Sussman JJ; Davidson BS; Gershenwald JE; Hagendoorn LJ; Stromberg AJ; Scoggins CR
    J Clin Oncol; 2016 Apr; 34(10):1079-86. PubMed ID: 26858331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the time interval between sentinel lymph node biopsy and completion lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study.
    Richtig G; Richtig E; Neiss AN; Quehenberger F; Gmainer DG; Kamolz LP; Lumenta DB
    Int J Surg; 2020 Mar; 75():160-164. PubMed ID: 32036082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.